The Journal of Biological Chemistry (JBC) is a weekly peer-reviewed scientific journal that was established in 1905. Since 1925 it is published by the American Society for Biochemistry and Molecular Biology. It covers research in any area of biochemistry or molecular biology. The editor-in-chief is Herbert Tabor. All its articles are available free one year after publication. In press articles are available free on its website immediately after acceptance. The journal was established in 1905 by John Jacob Abel and Christian Archibald Herter, who also served as the first editors; the first issue appeared in October 1905. The location of the journal s editorial offices has included Cornell Medical College (until 1937), Yale University (1937–1958), Harvard University (1958–1967), and New York (from 1967). The journal is currently published by the American Society for Biochemistry and Molecular Biology (ASBMB) at the ASBMB offices in Rockville, Maryland. The following individuals have served as editors-in-chief: The editors of the Journal of Biological Chemistry have criticized the modern reliance upon the impact factor for ranking journals, noting that review articles, commentaries,
A promising new stroke drug that temporarily inhibits a key protein in the brain without causing lasting harm may significantly change the future treatment of cerebral and global ischemia, according to a new study by scientists ...
May 23, 2023
0
44
Sensory neurons pick up information from our senses and relay it to the rest of the nervous system. But this is not their only mission. In a new study published in the journal Current Biology, Claire Wyart at the Paris Brain ...
Feb 15, 2023
0
63
Scientists are not yet clear on how the tau protein changes from a benign protein essential for normal function in our brains into the toxic neurofibrillary tangles that are a signature of Alzheimer's and other neurodegenerative ...
Feb 14, 2023
0
48
In a bit of "reverse engineering" research using brain tissues from five people who died with Alzheimer's disease, Johns Hopkins Medicine researchers say they discovered that a special sugar molecule could play a key role ...
May 27, 2022
0
241
When an individual suffers from cancer, the process of programmed cell death called apoptosis does not occur normally, permitting abnormal cells to thrive.
Jan 11, 2022
0
69
Immunotherapy, which harnesses the power of the body's immune system to fight disease, is gaining huge traction in treating cancer. Chief among cancer immunotherapies is a treatment known as CAR-T, or chimeric antigen receptor ...
Oct 4, 2021
0
85
University of Utah Health scientists have identified a molecule that slows cells' production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson's disease. Its discovery points ...
Sep 21, 2021
0
67
A new study led by researchers at Washington State University has identified a protein that could be the key to improving treatment outcomes after a heart attack.
Jun 2, 2021
0
11
A basic science discovery by researchers at the Johns Hopkins Bloomberg School of Public Health reveals a fundamental way cells interpret signals from their environment and may eventually pave the way for potential new therapies.
Nov 20, 2020
0
20
Researchers from Tokyo Metropolitan University have discovered a new mechanism by which clumps of tau protein are created in the brain, killing brain cells and causing Alzheimer's disease. A specific mutation to an enzyme ...
Oct 26, 2020
0
177
